Latest News and Press Releases
Want to stay updated on the latest news?
-
Imagine has announced over $11 million in strategic technology investments designed to further strengthen its production capabilities.
-
Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli...
-
Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Frost Radar: Workforce Engagement Management, 2025" report has been added to ResearchAndMarkets.com's offering.A Benchmarking System to Spark...
-
AGMH secured $25M ELOC and convertible notes; funds fuel AI ASIC chip R&D and global supply chain development, advancing its AI industrial chain layout.
-
Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "Understanding and Managing Contracts to Achieve Better Results Training Course (April 15-16, 2026)" training has been added to ...
-
Proprietary trading firm strengthens global footprint amid industry reset and shift away from challenge-based models
-
SAN FRANCISCO and SYDNEY, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Fundbox, the leading provider of embedded capital infrastructure for small businesses, today announced its expansion into Australia,...
-
GUELPH, Ontario, Jan. 20, 2026 (GLOBE NEWSWIRE) -- MOVATI Athletic, one of Canada’s leading fitness and wellness brands, is celebrating the 20th Anniversary of its Guelph Club with a special Open...
-
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...
-
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...